Cincinnati.com: UC joins national COVID impact study; you could be recruited for it
UC expert provides details on COMPASS study
Maggie Powers-Fletcher, PhD, of the Division of Infectious Diseases at the UC College of Medicine, was interviewed by Cincinnati.com about the COMPASS study she is leading. The study is part of the efforts by the COVID-19 Prevention Network launched by the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health. It will examine the impact of COVID-19 on communities across the United States.
Maggie Powers-Fletcher, PhD, of the Division of Infectious Diseases at the UC College of Medicine. Photo/Colleen Kelley/UC Creative + Brand
When the study is ready for enrollment, residents who happen to be in several pre-selected locations, or "pop-up sites" in public spaces around Cincinnati, will be recruited. The sites and recruitment efforts won't be announced in advance, so as not to taint the integrity of the study.
"I think it’s so cool that Cincinnati is involved and there’s no one else in our region that is doing this. This helps put Cincinnati on the map," Powers-Fletcher said. "This gives our community a voice in the larger federal government response of how we’re approaching solutions and approaching research related to this pandemic.”
Read the entire story here. See more coverage of the story from WLWT, WVXU and the Cincinnati Business Courier. Read more about the COMPASS study here.
Lead photo/Colleen Kelley/UC Creative + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
WLWT: Tips to fight off bad allergy symptoms
April 18, 2024
The University of Cincinnati's Ahmad Sedaghat spoke with WLWT about how Cincinnati's geography tends to make allergy symptoms worse and tips to fight off those symptoms.
Medscape: Skin adverse events rare after immunotherapy to treat...
April 17, 2024
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found skin adverse events were rare following immunotherapy treatments for certain skin cancers.
UC researchers develop new CPAP device
April 17, 2024
Researchers at the University of Cincinnati are developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.